Reduced AFG3L2 expression in lung adenocarcinoma stabilizes SLC25A39 and enhances oxidative phosphorylation (OXPHOS) and ROS handling, thereby promoting tumor progression [68]. The gene discussed is SLC25A39; the disease is lung adenocarcinoma.